ATEC
Alphatec Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.45
+1.29%Year over year
Reported trailing growth
- Revenue
- +19.5%
- EBITDA
- +128.8%
- EBIT
- +60.6%
- EPS
- +36.3%
- Free cash flow
- +113.8%
- Operating cash flow
- +260.3%
Forward estimates
Based on analyst estimates
- Revenue
- +16.4%
- EBITDA
- +1583.8%
- EPS
- +168.0%
Three-year CAGR
- Revenue
- +29.6%
- EBITDA
- +26.3%
- EBIT
- +39.7%
- Net income
- +11.6%
- EPS
- +15.0%
- Free cash flow
- +102.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026